In a mouse model of EGFR-mutated lung adenocarcinoma, which has a non-inflammatory immunosuppressive tumor microenvironment, EGFR signaling recruits CD4+ regulatory T cells and CD8+ T cell infiltration by activating JNK/cJun and inhibiting IRF1. This evidence concerns the gene IRF1 and neoplasm.